MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
Location status: Recruiting
NCT Number: NCT04258280
Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly your blood relatives, are at increased risk for the disease across the lifespan. This includes biological children, both male and female. We do not yet know the best ways to educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share genetic information with their children or manage their thoughts and feelings. The purpose of this study is to help mothers make more informed choices about talking with children about hereditary breast cancer, provide them with age-and gender-appropriate information and emotional support, and improve their psychological well-being.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Washington D.C., District of Columbia, 20007, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Education includes a workbook, counseling includes peer support.
Education includes a workbook.
Time frame: 1- and 6-months post-treatment
Parent-child and family communication of hereditary cancer risk.
Interested in participating?
Request InfoGeorgetown University
Other
Parent Communication Study IV: Improving Genetic Counseling for BRCA+ Mothers
Acronym: PCS IV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05766891
Breast Cancer, Breast Diseases
Houston, Texas, United States
View Trial DetailsNCT07054190
Breast Cancer, Breast Diseases
Los Angeles, California, United States
View Trial DetailsNCT03702309
Adnexal Diseases, BRCA1 Mutation
Toronto, Ontario, Canada
View Trial DetailsNCT06721065
Breast Cancer, Breast Cancer Stage II
Basking Ridge, New Jersey, United States
View Trial Details